For the quarter ending 2025-12-31, INBS has $17,653,042 in assets. $6,763,231 in debts. $740,371 in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Assets held for sale | 0 | 66,020 | 327,500 | |
| Cash and cash equivalents | 740,371 | 1,660,105 | 1,019,909 | |
| Accounts receivable, net | 456,657 | 717,823 | 594,614 | |
| Subscription receivable from shareholders, net | 9,402,105 | - | - | |
| Inventories | 590,246 | 628,177 | 635,215 | |
| Research and development tax incentive receivable | 505,172 | 924,062 | 734,408 | |
| Other current assets | 480,133 | 488,182 | 826,976 | |
| Total current assets | 12,174,684 | 4,484,369 | 4,138,622 | |
| Property and equipment, net | 321,741 | 271,745 | 251,325 | |
| Operating lease right-of-use assets | 1,887,178 | 1,808,892 | 69,520 | |
| Intangibles, net | 3,269,439 | 3,473,303 | 3,790,319 | |
| Total assets | 17,653,042 | 10,038,309 | 8,249,786 | |
| Accounts payable and accrued expenses | 4,261,236 | 3,992,427 | 4,534,246 | |
| Current portion of operating lease liabilities | 382,518 | 362,801 | 84,659 | |
| Current employee benefit liabilities | 470,486 | 567,059 | 534,990 | |
| Deferred grant income | - | - | 0 | |
| Notes payable | 13,001 | 139,787 | 197,146 | |
| Total current liabilities | 5,127,241 | 5,062,074 | 5,351,041 | |
| Employee benefit liabilities, less current portion | 106,926 | 100,041 | 84,921 | |
| Operating lease liabilities, less current portion | 1,529,064 | 1,449,265 | 0 | |
| Total liabilities | 6,763,231 | 6,611,380 | 5,435,962 | |
| Common stock, 0.01 par value, 100,000,000 shares authorized, 1,238,446 and 1,238,434 shares issued and outstanding, respectively, as of december31, 2025 732,338 and 732,326 shares issued and outstanding, respectively, as of june 30, 2025 | 12,384 | 90,985 | 73,230 | |
| Treasury stock, at cost, 12 shares as of december 31, 2025 and june 30, 2025 | 1 | 1 | 1 | |
| Additional paid-in capital | 79,540,489 | 69,325,542 | 65,783,916 | |
| Accumulated deficit | -68,193,661 | -65,516,071 | -62,533,065 | |
| Accumulated other comprehensive loss | -266,079 | -279,228 | -327,944 | |
| Total consolidated intelligent bio solutions inc. equity | 11,093,132 | 3,621,227 | 2,996,136 | |
| Non-controlling interest | -203,321 | -194,298 | -182,312 | |
| Total shareholders equity | 10,889,811 | 3,426,929 | 2,813,824 | |
| Total liabilities and shareholders equity | 17,653,042 | 10,038,309 | 8,249,786 | |
INTELLIGENT BIO SOLUTIONS INC. (INBS)
INTELLIGENT BIO SOLUTIONS INC. (INBS)